Search
  1. Home
  2. East Africa
  3. Tanzania
  • News

Joint HIV vaccine initiative with Sweden announced

    JOHANNESBURG

    HIV vaccine trials to be conducted in Sweden next month are expected to be extended to Tanzania in 2005.

    The vaccine, developed under the HIV Vaccine Immunogenicity Study, a European Union-funded partnership between the East African country and Sweden, is based on isolating a safe constituent of HIV DNA and injecting it into volunteers, who later receive an immunity-boosting shot.

    Mohammed Bakari, a senior member of the research team, told Reuters the DNA-MVA vaccine was intended to target HIV sub-types prevalent in Tanzania, where an estimated 2.2 million of the country's 34 million people are living with HIV/AIDS.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join